CORONANSECORONA Remedies Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 30 Jan, 2026 · 18:14 IST

CORONA Remedies reports 7 insider code violations by employees

Insider Trading ChargeRegulatory & Legal View source PDFExplain this filing

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.7%Reaction day
₹1486.00
prior close
₹1448.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.3%-0.5% vs market
Pharmaceuticals peers, median of 155sector-0.5%-1.2% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
+0.5
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.7-1.3-0.5-0.5-1.2
Next day
+1.3+2.4-1.1+1.4-0.2
2d
-1.0+3.8-4.8+1.6-2.6
3d
+3.3+2.7+0.6+0.8+2.5
4d
+3.6+1.9+1.7+0.4+3.3
5d
+9.6+4.6+5.0+2.2+7.4
1w
+9.6+5.1+4.6+2.5+7.2
15d
+6.1+2.1+4.1+0.5+5.6
1m
+8.7-2.1+10.8-1.9+10.6
2m
+0.9-6.4+7.4-6.5+7.4
3m
+16.7+9.5+7.2+3.1+13.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CORONA Remedies informed exchanges of 7 violations of the insider trading code by designated persons and their relatives. On December 15, 2025, all 7 traded shares during a trading window closure period, described as inadvertent. The company issued written warnings, levied penalties of about Rs 10,000 each (one of Rs 35,000), and required profit disgorgement from two of them. Total amounts have been paid to SEBI's Investor Protection Fund.

Likely market impact

Minor compliance lapse by 7 employees, already addressed with warnings and small penalties paid to SEBI. Negligible impact on shareholders.